Sushruta Med-Tech Innovation Labs And Enabler Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -1216.68%
(FY 2020)
- Ebitda -2354.87%
(FY 2020)
- Net Worth -329.17%
(FY 2020)
- Total Assets 68.28%
(FY 2020)
About Sushruta Med-Tech Innovation Labs And Enabler
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dayaprasad Kulkarni and Gurunath Kulkarni serve as directors at the Company.
- CIN/LLPIN
U85190KA2018PTC119087
- Company No.
119087
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sushruta Med-Tech Innovation Labs And Enabler?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dayaprasad Kulkarni  | Director | 03-Dec-2018 | Current |
| Gurunath Kulkarni | Director | 03-Dec-2018 | Current |
Financial Performance of Sushruta Med-Tech Innovation Labs And Enabler.
Sushruta Med-Tech Innovation Labs And Enabler Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1216.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 329.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sushruta Med-Tech Innovation Labs And Enabler?
Unlock access to Sushruta Med-Tech Innovation Labs And Enabler's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Handbloom Sustainable Lifestyle Solutions Private LimitedActive 5 months 10 daysDayaprasad Kulkarni is a mutual person
- Saubha Vimana Autonomous Drone Systems Private LimitedActive 5 months 24 days
Dayaprasad Kulkarni is a mutual person
- Ahimsa Pharmaceuticals Private LimitedActive 6 months 7 days
Dayaprasad Kulkarni and Gurunath Kulkarni are mutual person
- Phpcg Health Private LimitedInactive For E-Filing 5 months 26 days
Dayaprasad Kulkarni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sushruta Med-Tech Innovation Labs And Enabler?
Unlock and access historical data on people associated with Sushruta Med-Tech Innovation Labs And Enabler, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sushruta Med-Tech Innovation Labs And Enabler, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sushruta Med-Tech Innovation Labs And Enabler's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
